|
2. BİLİMSEL ÇALIŞMALAR: 2.1. Doktora veya İhtisas Tezi: Mide Kanseri için yeni peri adjuvan tedavi stratejileri. Tez Danışmanı: Prof. Dr. Howard Bruckner, Mount Sinai Tıp Fakültesi İleri safha pankreas kanserinde kombine tedavi uygulaması ve uzun dönemli takibi. Tez Danışmanı: Prof. Dr. Howard Bruckner, Mount Sinai Tıp Fakültesi 2.2. Doktora veya ihtisas tezinden yayınlanmış makaleler: A. DOÇENTLİK ÖNCESİ 2.2.1. Turhal NS, Bruckner HW. “New neoadjuvant treatment strategies for gastric and gastroesophageal junction cancers”, Marmara Medical Journal 1999 12(1): 20-24. 2.2.2. Turhal NS, Terk M, Bruckner HW. “Combined Modality Therapy for Pancreatic Cancer”. Turkish Journal of Cancer, 1999 11(2): 55-64. 2.3. Doktora veya ihtisas tezi dışında yayınlanmış makaleler: 2.3.1. Uluslararası hakemli dergilerde yayımlanan makaleler : A. DOÇENTLİK ÖNCESİ 2.3.1.1. Turhal N, Sullivan MB, Blakemore WS. Thyroglossal Duct Cyst. South Med J, 1990, 83:8, 983-4. Atıflar: 2 adet 2.3.1.2. Turhal N, DeLuca VA Jr. Ulcerative Colitis and Scleroderma. A coincidental relationship. J Clin Gastroenterol. 1994, 18:3, 218-9. Atıflar: 1 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=14087877503050283226 2.3.1.3. Turhal NS, Henehan MD, Kaplan KL. Multiple myeloma: a patient with unusual features including intracranial and meningeal involvement, testicular involvement, organomegaly, and plasma cell leukemia. Am J Hematol 1998, 57:1, 51-56. Atıflar: 5 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=16038244302575248353 2.3.1.4. Turhal NS. Cyclosporin A and Imipenem Associated Seizure Activity in Allogeneic Bone Marrow Transplantation Patients. Journal of Chemotherapy 1999 11(5): 410-413. Atıflar: 1 adet B. DOÇENTLİK SONRASI 2.3.1.5. Turhal NS, Erdal S, Karacay S. Efficacy of the Treatment to Relieve Mucositis Induced Discomfort. Supportive Care in Cancer 2000 8(1): 55-58. Atıflar: 11 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=9224762740491128396 2.3.1.6. Turhal NS. Pancreatic Duct Cell Carcinoma with Positive In-111 Octreotide Uptake. Journal of Experimental and Clinical Cancer Research 2000 19(2): 241-244. Atıflar: 1 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=3086857171421125646 2.3.1.7. Turhal NS. Sumatriptan overdose in episodic cluster headache: a case report of overuse without event. Cephalalgia. 2001 21:700. Atıflar: 2 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=3305478064832093771 2.3.1.8. Turhal NS, Rand J. Antiphospholipid syndrome in HIV infection - Report of four cases and review of literature. Allergy & Clinical Immunology International 2001 13(6):1- 4. Atıflar: 4 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=7397992836540309533 2.3.1.9. Duman D, Turhal NS, Duman DG, M.D. Fatal Aplastic Anemia during Treatment with Ketoconazole. American Journal of Medicine 2001, 111:9 Atıflar: 2 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=3117564245376579991 2.3.1.10. Turhal NS. Two cases of advanced renal cell cancer with prolonged survival of 8 and 12 years. Japanese Journal of Clinical Oncology 2002 32(4): 152-153 Atıflar: 1 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=13935624351722493486 2.3.1.11. Turhal NS, Gumus M, Atalay G, Aliustaoglu M, Kabakas F, Karamanoglu A, Sengoz M. Outpatient cancer care in a Turkish university hospital. Journal of BUON 2002 7(4): 397-398. 2.3.1.12. Turhal NS, Efe B, Gumus M, Aliustaoglu M, Karamanoglu A, Sengoz M. Patient satisfaction in the outpatients’ chemotherapy unit of Marmara University, Istanbul, Turkey: a staff survey. BMC Cancer 2002 2(1): 30-33. Atıflar: 1 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=10755444610255035949 2.3.1.13. Turhal NS, Aliustaoglu M, Gurses I, Gumus M, Atalay G, Karamanoglu A, Sengoz M. Neoplastic diseases prevalence in a Turkish university hospital. Journal of BUON 2003 8(1): 45-48. 2.3.1.14. Karamanoglu A, Yumuk PF, Gumus M, Aliustaoglu M, Selimen D, Sengoz M, Turhal NS. Port needles: Do they need to be removed as frequently in infusional chemotherapy? Journal of Infusional Nursing 2003 26(4):239-242 Atıflar: 3 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=3285498604753279414 2.3.1.15. Abacıoglu U, Sengoz M, Yumuk F, Salepci T, Turhal NS. Cisplatin and etoposide in extra pulmonary small cell cancer. Tumori 2003 89(3): 274-277. Atıflar: 20 adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=12670133082976671960 2.3.1.16. Yumuk PF, Abacioglu U, Caglar H, Gumus M, Sengoz M, Turhal NS. Outcome of rectum and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital. J Chemother 15 (6): 603-606, 2003. 2.3.1.17. Turhal NS, Dane F, Dede F, Gumus M, Yumuk PF, Cakalagaoglu F, Savcı D, Karaman M, Gulluoglu B, Turoglu HT. 99m-Tc-MDP Scintimammography to assess angiogenesis in patients with untreated breast cancer. Anticancer Research. 24:1999- 2006 (2004) Atıflar: 1 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=8066682829616811384 2.3.1.18. Yumuk PF, Gumus M, Ekenel M, Basaran G, Aliustaoglu M, Topal A, Turhal NS, N. Attitude Toward Genetic Testing in Turkish Society. Genetic Testing 8(2):169-173, 2004 Atıflar: 2 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=12681732269582698398 2.3.1.19. Yumuk PF, Aydin SZ, Dane F, Gumus M, Ekenel M, Aliustaoglu M, Karamanoglu A, Sengoz M, Turhal NS. The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients. International Journal of Colorectal Disease 19: 609-610, 2004. 2.3.1.20. Bolukbas FF, Kılıc H, Bolukbas C, Gumus M, Horoz M, Turhal NS, Kavalı B. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer 2004, 4:29-32. Atıflar: 7 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=17826764500982860129 2.3.1.21. Yumuk PF, Abacioglu U, Demir G, Cabuk D, Dane F, Gumus M, Ozguroglu M, Ekenel M, Basaran G, Turhal NS. Does the Incidence of Anal Canal Cancers Differ in Moslem Societies? International Journal of Colorectal Disease, Clinical and Molecular Gastroenterology and Surgery. 10.1007/s00384-004-0614-4. 2004. 2.3.1.22. Aliustaoglu M, Yumuk PF,Gumus M, Ekenel M, Bolukbas F, Mutlu N, Basaran G, Avsar E, Turhal NS. D-Dimer—Can it be a marker for malignant gastric lesions. Acta Oncologica, 2004 Dec 43(8) 770-771. Atıflar: 2 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=10828204231987902171 2.3.1.23. Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, Moore J, Koller M, Turhal NS, Stuart R, Van Cutsem E, D’Haese S, Coens C. Clinical and Psychometric validation of a questionnaire module, The EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer, 2004 Oct 40(15): 2260-8 Atıflar: 13 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=7446152185685022904 2.3.1.24. Gumus M, Yumuk PF, Atalay G, Aliustaoglu M, Macunluoglu B, Dane F, Caglar H, Sengoz M, Turhal S. What should be the optimal number of lymph nodes dissected in colorectal Cancer surgery? Tumori, 172/03. 11 2004. PROFESÖRLÜK SONRASI 2.3.1.25. Yumuk PF, Turhal NS, Gumus M, Hatabay NF, Turken O, Ozkan A, Salepci T, Aliustaoglu M, Ahiskali R, “Results of paclitaxel (day 1 and 8) and Carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung Cancer”, BMC Cancer, (MS:7372801141679098), 2005 March, 21 2.3.1.26. Abacioğlu U, Yumuk PF, Caglar H, Sengoz M, Turhal NS, “Concurrent chemoradiotherapy with low dose weekly Gemcitabine in stage III non-small cell lung cancer.” BMC Cancer. 2005 Jul, 6;5:71 Atıflar: 3 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=4020091328951835599 2.3.1.27. Onol FF, Tanidir Y, Kotiloglu E, Bayramicli M, Turhal NS, Turkeri LN. “Proximal type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention.” Eur Urol. 2006 Feb; 49(2):7. Epub 2005 Nov 7. Atıflar: 2 Adet http://scholar.google.com.tr/scholar?hl=tr&lr=&cites=5503029184430428787 2.3.1.28. Onol FF, Tanidir Y, Kotiloglu E, Bayramicli M, Turhal NS, Turkeri LN. “Proximal type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention: Part 2.” Eur Urol 2006 Mar 49(3):578-80. 2.3.1.29 Gumus M, Yumuk PF, Salepci T, Aliustaoglu M, Dane F, Ekenel M, Basaran G, Kaya H, Barisik N, Turhal NS. “HPV DNA frequency and subset analysis in human breast cancer patients normal and tumoral tissue samples.” J Exp Clin Cancer Res. 2006 Dec;25(4):515-21. 2.3.1.30 Komurcu S, Turhal NS, Altundag K, Atahan L, Turna HS, Manavoglu O, Yavuz AA, Ozkok S, Aliustaoglu M, Altinbas M, Pak Y, Cooper R, Yaylaci M, Demirkan B, Sarihan S, Ozdemir F. “Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish Oncology group trial.” Eur J Cancer Care (Engl). 2007 Jan; 16(1):67-73 2.3.1.31. Turhal NS, Popov IP. “Colorectal cancer care in the Balkan countries.” J BUON 2005 Apr-Jun;10(2):189-93 2.3.1.32. Atasoy BM, Abacioglu U, Dane F, Ozgen Z, Yumuk PF, Ozden S, Akgun Z, Mayadagli A, Basaran G, Turhal NS, Sengoz M. “Concomitant administration of uraciltegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.” J BUON. 2007 Apr-Jun;12(2):203-8. 2.3.1.33. Celikel C, Eren F, Gulluoglu B, Bekiroglu N, Turhal NS. “Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications.” Pathol Oncol Res. 2007:13(3):215-26. Epub 2007 Oct 7. 2.3.1.34. Cabuk D, Basaran G, Celikel C, Dane F, Yumuk PF, Iyikesici MS, Ekenel M, Turhal NS. “Vascular Endothelial Growth Factor, Hypoxia-Inducible Factor 1 Alpha and CD34 Expressions in Early-Stage Gastric Tumors: Relationship with Pathological Factors and Prognostic Impact on Survival.” Oncology. 2007 Nov 15;72(1-2):111-117. 2.3.2. Ulusal hakemli dergilerde yayımlanan makaleler : A. DOÇENTLİK ÖNCESİ 2.3.2.1. Turhal NS. “Metastatik meme kanseri yaygın kemik metastazlarında tedavi”, Kanser Gündemi, Türkiye Kanserle Savaş Vakfı, 1998 3(3): 118-121. 2.3.2.2. Turhal NS. “Yetişkin kanser hastalarında transfüzyon tedavisi yaklaşımları” Damla, Kan Merkezleri ve Transfüzyon Derneği Bülteni, 1998 22:4-7. 2.3.2.3. Turhal NS. “Meme kanserinin biyolojik tedavisinde: Herceptin, Academic Hospital 1998 4:16-18. 2.3.2.4. Turhal NS, Tanju P, Pekin S. “Serviks kanseri etyolojisine yönelik standart ve gelecek vadeden tarama yaklaşımları” Hekimler Birliği Vakfı, Türkiye Klinikleri, Jinekolojik Obstetrik, 1999 9(3): 215-220. 2.3.2.5. Turhal NS, Akdas A. “Prostat kanserinde gen tedavisi uygulaması ve sorunları” Üroloji Bülteni 1999 10(1): 5-11.
|
